America February 12, 2024
Gilead To Buy CymaBay For $4.3B : A Liver Health Power Play
In a bold move poised to reshape the landscape of liver disease treatment, Gilead Sciences Inc. has announced its acquisition…
America February 12, 2024
In a bold move poised to reshape the landscape of liver disease treatment, Gilead Sciences Inc. has announced its acquisition…
By Rihem Akkouche
America February 8, 2024
Cell therapy innovator, Kyverna Therapeutics Inc., embarks on a thrilling journey to debut in the trading arena after an electrifying…
By Rihem Akkouche
America February 5, 2024
In a startling revelation, Cano Health Inc., a prominent primary care group, has initiated Chapter 11 protection proceedings in Delaware…
By Rihem Akkouche
America February 5, 2024
Data from the National Cancer Institute reveals cancer is a pervasive illness that far too many Americans struggle with. While…
By Gabrielle Seunagal
America January 31, 2024
In a groundbreaking move, the Cigna Group has announced the sale of various health benefits and Medicare units to Health…
By Rochdi Rais
America January 30, 2024
In the labyrinth of global mergers and acquisitions, a select few have embraced the power of generative artificial intelligence, igniting…
By Rihem Akkouche
America January 25, 2024
In a groundbreaking move, Arlington Capital Partners, guided by legal counsel Kirkland & Ellis LLP, triumphantly announced the successful closure…
By Rihem Akkouche
America January 6, 2024
In a dramatic legal showdown, the American Hospital Association, joined by three other healthcare organizations, has launched a fervent appeal…
By Rochdi Rais
America January 5, 2024
In an exhilarating turn of events, Leavitt Equity Partners announced the triumphant closure of its third private equity fund, Leavitt…
By Rihem Akkouche
America January 5, 2024
In a groundbreaking decision, the U.S. Food and Drug Administration (FDA) granted approval on Friday to Florida’s pioneering initiative, marking…
By Rihem Akkouche